(Q43647546)

25 November 2017

title

Separation and determination of liposomal and non-liposomal daunorubicin from the plasma of patients treated with Daunoxome (English)

1 reference

25 November 2017

1 reference

Jacques Robert

3

0 references

author name string

Bellott R

1

1 reference

25 November 2017

Pouna P

2

1 reference

25 November 2017

Robert J

3

1 reference

25 November 2017

Ricardo Bellott

1

0 references

Paul Pouna

2

0 references

publication date

1 June 2001

1 reference

Journal of Chromatography B: Biomedical Sciences and Applications

25 November 2017

June 2001

0 references

published in

1 reference

25 November 2017

volume

757

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

257-267

1 reference

Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

Liposome-encapsulated daunorubicin for PGP-related multidrug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

Failure of liposomal encapsulation of doxorubicin to circumvent multidrug resistance in an in vitro model of rat glioblastoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: implications for pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

Extraction of Anthracyclines from Biological Fluids for HPLC Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900151-7

7 January 2021

10.1016/S0378-4347(01)00151-7

Identifiers

DOI

0 references

1 reference